42.58
1.46 (3.55%)
| Previous Close | 41.12 |
| Open | 41.91 |
| Volume | 515,872 |
| Avg. Volume (3M) | 1,103,747 |
| Market Cap | 1,226,864,128 |
| Price / Earnings (TTM) | 9.68 |
| Price / Earnings (Forward) | 98.04 |
| Price / Sales | 1.37 |
| Price / Book | 1.55 |
| 52 Weeks Range | |
| Earnings Date | 3 Aug 2026 |
| Profit Margin | 7.92% |
| Operating Margin (TTM) | -0.74% |
| Diluted EPS (TTM) | 2.19 |
| Quarterly Revenue Growth (YOY) | 22.70% |
| Quarterly Earnings Growth (YOY) | 138.60% |
| Total Debt/Equity (MRQ) | 5.27% |
| Current Ratio (MRQ) | 9.01 |
| Operating Cash Flow (TTM) | 114.68 M |
| Levered Free Cash Flow (TTM) | 42.41 M |
| Return on Assets (TTM) | 4.40% |
| Return on Equity (TTM) | 10.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Inspire Medical Systems, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.25 |
|
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 1.11% |
| % Held by Institutions | 119.04% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Deerfield Management Company, L.P. | 31 Mar 2026 | 2,703,238 |
| Soleus Capital Management, L.P. | 31 Mar 2026 | 576,299 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |